| Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection IC Yilmaz, EM Ipekoglu, A Bulbul, N Turay, M Yildirim, I Evcili, NS Yilmaz, ... Allergy 77 (1), 258-270, 2022 | 46 | 2022 |
| Gene network landscape of mouse splenocytes reveals integrin complex as the A151 ODN-responsive hub molecule in the immune transcriptome V Yazar, IC Yilmaz, A Bulbul, DM Klinman, I Gursel Molecular Therapy-Nucleic Acids 31, 553-565, 2023 | 1 | 2023 |
| LARGE-SCALE MANUFACTURING AND CHARACTERIZATION OF A SARS-COV-2 VIRUS-LIKE PARTICLE VACCINE ADSORBED ONTO ALHYDROGEL AND ADJUVANTED WITH K3 CPG OLIGODEOXYNUCLEOTIDE FOR PHASE 1 … A Bülbül Bilkent University, 2022 | | 2022 |
| Manufacturing of a SARS-CoV-2 virus-like particle vaccine adjuvanted with K3 CpG oligodeoxynucleotide and alhydrogel for phase 1/2 clinical trials A Bulbul, IC Yilmaz, N Yilmaz, N Turay, EM Ipekoglu, N Guvencli, ... EUROPEAN JOURNAL OF IMMUNOLOGY 51, 370-370, 2021 | | 2021 |
| Ex vivo Th-1 biasing T cell responses in alum-adsorbed SARS-CoV-2 inactivated virus vaccine adjuvanted with K-type CpG ODN EM Ipekoglu, M Yildirim, TC Yildirim, B Saraydar, KT Bildik, I Evcili, ... EUROPEAN JOURNAL OF IMMUNOLOGY 51, 368-368, 2021 | | 2021 |
